Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and DDI Study of Anaprazole Quadruple Therapy in Healthy Chinese Males
NCT04444011Phase 1Unknown
- Sponsor
- Sihuan Pharmaceutical
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Anaprazole in Helicobacter pylori infection (2 cohorts), sponsored by Sihuan Pharmaceutical. Primary endpoints: Maximum Plasma Concentration (Css,max) at Day 47, Area Under the Curve at Day 47 and 1 more. Status: unknown.
02
Drugs
Anaprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04444011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04444011.